• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性非肝硬化性门静脉高压症的病理学。

Pathology of idiopathic non-cirrhotic portal hypertension.

机构信息

Surgical Pathology & Cytopathology Unit, Department of Medicine - DIMED, University of Padova, Padua, Italy.

Department of Internal Medicine, San Pietro Hospital, Ponte San Pietro, Italy.

出版信息

Virchows Arch. 2018 Jul;473(1):23-31. doi: 10.1007/s00428-018-2355-8. Epub 2018 Apr 12.

DOI:10.1007/s00428-018-2355-8
PMID:29644430
Abstract

Idiopathic non-cirrhotic portal hypertension is an under-recognized vascular liver disease of unknown etiology, characterized by clinical signs of portal hypertension in the absence of cirrhosis. By definition, any disorder known to cause portal hypertension in the absence of cirrhosis and any cause of chronic liver disease must be excluded to make a diagnosis of idiopathic non-cirrhotic portal hypertension. However, the diagnosis is often difficult because the disease resembles cirrhosis and there is no gold standard test. Liver biopsy is an essential tool: it is able to exclude cirrhosis and other causes of portal hypertension and it allows the identification of the characteristic lesions. Nonetheless, the histological diagnosis of idiopathic non-cirrhotic portal hypertension is not always straightforward, in particular by needle biopsy samples, because there is no pathognomonic lesion, but rather a variety of vascular changes which are unevenly distributed, very subtle, and not all necessarily identified in a single specimen. Pathologists should be able to recognize several patterns of injury, involving portal/periportal areas as well as parenchymal structures.The histological features of idiopathic non-cirrhotic portal hypertension are described in this review, focusing on their interpretation in needle biopsy specimens.

摘要

特发性非肝硬化性门静脉高压症是一种未被充分认识的血管性肝脏疾病,其特征为在无肝硬化的情况下出现门静脉高压的临床征象。根据定义,任何已知可导致无肝硬化性门静脉高压的疾病以及任何慢性肝病的病因均需排除,以作出特发性非肝硬化性门静脉高压症的诊断。然而,由于该疾病类似于肝硬化且缺乏金标准检测,因此诊断通常较为困难。肝活检是一种重要的工具:它能够排除肝硬化和其他门静脉高压的病因,并可识别特征性病变。尽管如此,特发性非肝硬化性门静脉高压症的组织学诊断并不总是明确的,特别是通过针芯活检样本,因为没有特征性病变,而是存在多种血管改变,这些改变分布不均、非常细微,并非所有病变在单个标本中都能识别。病理学家应该能够识别几种损伤模式,包括门脉/门周区域以及实质结构。本文重点介绍了特发性非肝硬化性门静脉高压症的组织学特征,同时关注了其在针芯活检标本中的解读。

相似文献

1
Pathology of idiopathic non-cirrhotic portal hypertension.特发性非肝硬化性门静脉高压症的病理学。
Virchows Arch. 2018 Jul;473(1):23-31. doi: 10.1007/s00428-018-2355-8. Epub 2018 Apr 12.
2
Obliterative portal venopathy without portal hypertension: an underestimated condition.无门静脉高压的闭塞性门静脉病:一种被低估的病症。
Liver Int. 2016 Mar;36(3):454-60. doi: 10.1111/liv.12936. Epub 2015 Sep 6.
3
Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition.特发性非肝硬化性门静脉高压相关门静脉血管改变的组织学:命名和定义。
Histopathology. 2019 Jan;74(2):219-226. doi: 10.1111/his.13738. Epub 2018 Oct 17.
4
Idiopathic noncirrhotic portal hypertension.特发性非肝硬化性门静脉高压症。
Semin Diagn Pathol. 2019 Nov;36(6):395-403. doi: 10.1053/j.semdp.2019.07.006. Epub 2019 Jul 24.
5
Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study.特发性门静脉高压症的肝脏病理学。与印度非肝硬化性门脉纤维化的比较。日本特发性门静脉高压症研究。
Liver. 1982 Sep;2(3):176-92. doi: 10.1111/j.1600-0676.1982.tb00195.x.
6
Clinicopathological features of nine cases of non-cirrhotic portal hypertension: current definitions and criteria are inadequate.9例非肝硬化性门静脉高压症的临床病理特征:现行定义和标准并不充分。
Histopathology. 2003 Mar;42(3):251-64. doi: 10.1046/j.1365-2559.2003.01586.x.
7
Spectrum of histopathological changes in patients with non-cirrhotic portal fibrosis.非肝硬化性门静脉纤维化患者的组织病理学变化谱。
Hepatol Int. 2018 Mar;12(2):158-166. doi: 10.1007/s12072-018-9857-y. Epub 2018 Apr 12.
8
Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology.病因不明的非肝硬化门静脉高压症的肝脏组织病理学
Histopathology. 1996 Mar;28(3):195-204. doi: 10.1046/j.1365-2559.1996.d01-412.x.
9
Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly.86例特发性门静脉高压症的临床研究及与脾肿大性肝硬化的比较。
Gastroenterology. 1984 Apr;86(4):600-10.
10
Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis.非肝硬化性门静脉高压(闭塞性门静脉病)是囊性纤维化中慢性肝病的主要形式。
Ir J Med Sci. 2023 Aug;192(4):1657-1660. doi: 10.1007/s11845-022-03153-0. Epub 2022 Sep 17.

引用本文的文献

1
Gastrointestinal Manifestations of Common Variable Immunodeficiency: A Mentored Review.普通可变免疫缺陷的胃肠道表现:一篇有指导的综述
Dig Dis Sci. 2025 Jun 2. doi: 10.1007/s10620-025-09106-8.
2
IgA nephropathy, non-cirrhotic portal fibrosis, and POEMS syndrome: A rare combination in the long-term follow-up of Sjögren's syndrome.IgA肾病、非肝硬化性门脉纤维化与POEMS综合征:干燥综合征长期随访中的罕见组合。
J Int Med Res. 2025 Apr;53(4):3000605251332903. doi: 10.1177/03000605251332903. Epub 2025 Apr 30.
3
Idiopathic non-cirrhotic portal hypertension: A case report.

本文引用的文献

1
Transient Elastography (Fibroscan) in Patients with Non-cirrhotic Portal Fibrosis.非肝硬化性门脉纤维化患者的瞬时弹性成像(Fibroscan)
J Clin Exp Hepatol. 2017 Sep;7(3):230-234. doi: 10.1016/j.jceh.2017.03.002. Epub 2017 Mar 14.
2
Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies.一般人群中特发性非肝硬化性门静脉高压的组织学特征的流行情况:偶然肝活检的回顾性研究。
Hepatol Int. 2017 Sep;11(5):452-460. doi: 10.1007/s12072-017-9801-6. Epub 2017 Jun 8.
3
Idiopathic noncirrhotic portal hypertension: current perspectives.
特发性非肝硬化性门静脉高压症:一例报告。
Medicine (Baltimore). 2024 Dec 20;103(51):e40642. doi: 10.1097/MD.0000000000040642.
4
Link between persistent, unexplained gamma-glutamyltransferase elevation and porto-sinusoidal vascular disorder.持续性不明原因γ-谷氨酰转移酶升高与门-肝窦血管疾病之间的关联。
JHEP Rep. 2024 Jun 23;6(9):101150. doi: 10.1016/j.jhepr.2024.101150. eCollection 2024 Sep.
5
Histopathological features of idiopathic portal hypertension: A systematic review and meta-analysis.特发性门静脉高压症的组织病理学特征:系统评价和荟萃分析。
Sci Prog. 2024 Jul-Sep;107(3):368504241264996. doi: 10.1177/00368504241264996.
6
Porto-sinusoidal vascular disease: a new definition of an old clinical entity.门静脉窦状隙血管疾病:一种旧有临床实体的新定义。
Clin Exp Hepatol. 2023 Dec;9(4):297-306. doi: 10.5114/ceh.2023.133107. Epub 2023 Nov 24.
7
Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH).特发性非肝硬化性门静脉高压症(INCPH)的组织学和免疫组织化学(CD34、谷氨酰胺合成酶)表现评估。
Hepatol Int. 2024 Jun;18(3):1011-1019. doi: 10.1007/s12072-024-10654-w. Epub 2024 Mar 27.
8
Case report: Oxaliplatin-induced idiopathic non-cirrhotic portal hypertension: a case report and literature review.病例报告:奥沙利铂诱导的特发性非肝硬化门静脉高压症:一例病例报告及文献综述
Front Med (Lausanne). 2023 Nov 28;10:1285064. doi: 10.3389/fmed.2023.1285064. eCollection 2023.
9
Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis.血管性肝脏疾病的分子机制:聚焦于血栓形成。
Int J Mol Sci. 2023 Aug 13;24(16):12754. doi: 10.3390/ijms241612754.
10
Spectrum of Liver Pathology in Dyskeratosis Congenita.先天性角化不良症的肝脏病理学谱。
Am J Surg Pathol. 2023 Aug 1;47(8):869-877. doi: 10.1097/PAS.0000000000002060. Epub 2023 May 29.
特发性非肝硬化性门静脉高压症:当前观点
Hepat Med. 2016 Jul 27;8:81-8. doi: 10.2147/HMER.S85544. eCollection 2016.
4
Non-cirrhotic portal fibrosis at a tertiary care centre in South India.印度南部一家三级医疗中心的非肝硬化性门脉纤维化
Trop Doct. 2017 Jan;47(1):26-30. doi: 10.1177/0049475516636982. Epub 2016 Mar 16.
5
Atrophic hepatocytes express keratin 7 in ischemia-associated liver lesions.萎缩的肝细胞在缺血相关肝损伤中表达细胞角蛋白7。
Histol Histopathol. 2016 Oct;31(10):1089-94. doi: 10.14670/HH-11-738. Epub 2016 Feb 18.
6
Idiopathic non-cirrhotic portal hypertension: the tip of the obliterative portal venopathies iceberg?特发性非肝硬化性门静脉高压症:闭塞性门静脉病冰山之一角?
Liver Int. 2016 Mar;36(3):325-7. doi: 10.1111/liv.13048.
7
Idiopathic Noncirrhotic Portal Hypertension: An Appraisal.特发性非肝硬化门静脉高压症:一项评估
J Pathol Transl Med. 2016 Jan;50(1):17-25. doi: 10.4132/jptm.2015.09.23. Epub 2015 Nov 11.
8
EASL Clinical Practice Guidelines: Vascular diseases of the liver.欧洲肝脏研究学会临床实践指南:肝脏血管疾病
J Hepatol. 2016 Jan;64(1):179-202. doi: 10.1016/j.jhep.2015.07.040. Epub 2015 Oct 26.
9
Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.肝活检中结节性再生性增生的患病率及临床意义
Liver Int. 2016 Jul;36(7):1059-66. doi: 10.1111/liv.12974. Epub 2015 Oct 19.
10
Obliterative portal venopathy without portal hypertension: an underestimated condition.无门静脉高压的闭塞性门静脉病:一种被低估的病症。
Liver Int. 2016 Mar;36(3):454-60. doi: 10.1111/liv.12936. Epub 2015 Sep 6.